ArticleThoracic cancer2026
Advantage of Sleeve Right Lower Lobectomy for Lung Cancer in COPD Patients: A Case Series.
Article in Thoracic cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Advantage of Sleeve Right Lower Lobectomy for Lung Cancer in COPD Patients: A Case Series.Thoracic cancer · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sleeve right lower lobectomy (SRLL) is an uncommon procedure for right lower lobe lung cancer involving the intermediate bronchus, mainly because it is more technically demanding than lower bilobectomy (LBL), particularly due to challenges such as bronchial caliber mismatch and anastomotic tension. We retrospectively reviewed four chronic obstructive pulmonary disease (COPD) patients who underwent SRLL at Akita University Hospital (2020-2023). All cases had squamous cell carcinoma pStage IB-IIB. Postoperative respiratory function exceeded the predicted postoperative values for LBL and even for right lower lobectomy, suggesting preservation of pulmonary function beyond initial estimates. One bronchopleural fistula occurred, but it healed with conservative treatment. No recurrences were observed. SRLL with middle lobe preservation may improve outcomes by reducing complications and preserving pulmonary function, especially in COPD patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.